Please assess the completion status of the following clinical trial:

Trial Title: Wearable Sensors in Knee OA

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 50 years of age~* A confirmed clinical diagnosis of osteoarthritis of the knee based on American College of Rheumatology criteria (confirmed by the participant's physician).~* Score ≥ 3 on weight-bearing questions from the Knee injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale in the index knee~* BMI ≤ 40 kg/m2~* Able to walk without assisted devices (eg. cane or walker) for at least 20 minutes~* Can speak and understand English~* Available for the study duration~Exclusion Criteria:~* Contraindication to exercise~* Other pain in lower back or legs that is greater than knee pain~* Currently receiving chemotherapy or radiation therapy for cancer except non-melanoma skin cancer~* History of other disease that may involve the index joint including inflammatory joint disease such as rheumatoid arthritis, seronegative spondyloarthropathy (eg, ankylosing spondylitis, psoriatic arthritis, inflammatory bowel disease related arthropathy), crystalline disease (eg, gout or pseudogout), lupus erythematosus, knee joint infections, Paget's disease affecting the knee, or knee joint tumors.~* Any knee surgery in the previous 6 months~* Previous knee osteotomy, uni-compartmental replacement, or total knee replacement in either knee~* Joint replacement in either hip or ankle~* Planned major treatment for knee OA (e.g., surgery, injections, physical therapy) during the study period~* Planned major surgery in the next 6 months~* Corticosteroid or hyaluronic acid injections in either knee in the previous 3 months~* Neurological conditions that impacts motor functioning, for e.g., stroke, Parkinson's disease, Alzheimer's disease, Multiple Sclerosis, diabetic neuropathy, etc.~* Pregnant~* Received physical therapy for knee OA within past 6 months~* Known or suspected non-compliance, drug or alcohol abuse~* Participation in another clinical trial for treatment of any joint or muscle pain~* Participants who are investigational site staff members directly involved in the conduct of the study and their family members, site staff members otherwise supervised by the Investigators.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Exercise-based Physical Therapy (Type: EXPERIMENTAL): 12 week in-person exercise-based physical therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).